Novo Nordisk Lowers Wegovy Price by 30% for Cash-Paying PatientsBusiness PenNovember 17, 2025April 22, 2026 November 17, 2025April 22, 2026 [stock_market_widget type=”card” template=”basic2″ assets=”NVO” realtime=”true” api=”yahoo-finance”] Novo Nordisk (NYSE: NOVO) has announced a significant 30% reduction in the cash price of its obesity drug Wegovy,...